Home > > Global Human Milk Oligosaccharides Market Report
The Human Milk Oligosaccharides market was valued at $21.4 Million in 2022, and is projected to reach $132.1 Million by 2032 growing at a CAGR of 20.10% from 2023 to 2032.Human milk oligosaccharides (HMOs) are complex sugars found in human breast milk that are believed to have numerous health benefits for infants. The market for HMOs is driven by increasing awareness of the benefits of breast milk and the growing demand for infant formula that contains HMOs. One of the major trends in the HMO market is the development of techniques for large-scale production of HMOs, which has the potential to make these ingredients more widely available and affordable. There are several companies that are actively involved in the production and research of HMOs, including Glycosyn, Glycom, and Bioseeln. These companies have developed various technologies for the production of HMOs, including fermentation and chemical synthesis, and are working on improving the efficiency and scalability of these processes. Another trend in the HMO market is the increasing focus on developing infant formula products that contain HMOs, as more and more parents are looking for alternatives to breastfeeding. There are also opportunities in the market for the development of HMO-based products for other age groups, such as adults and elderly individuals.